RECRUITING

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.

Official Title

Evaluation of Frequency Allocation Tables for Recently Implanted Single-Sided Deaf Cochlear Implant Users

Quick Facts

Study Start:2024-01-04
Study Completion:2029-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07039435

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 or older
  2. 2. No known anatomical abnormalities in either ear
  3. 3. English speaking
  4. 4. Intends to receive a cochlear implant in one ear (or has already received it but it has not been activated).
  5. 5. Normal hearing (or minimal hearing loss) in the contralateral ear
  1. 1. Under age 18
  2. 2. Documented anatomical abnormality of the implanted ear
  3. 3. Non-English speaking
  4. 4. Greater than minimal hearing loss in the contralateral ear.

Contacts and Locations

Study Contact

Mario A. Svirsky, PhD
CONTACT
646-284-2457
Mario.svirsky@nyulangone.org
Nicole H. Capach, AuD
CONTACT
646-501-6905
Nicole.capach@nyulangone.org

Principal Investigator

Mario A. Svirsky, PhD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Mario A. Svirsky, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-04
Study Completion Date2029-07-31

Study Record Updates

Study Start Date2024-01-04
Study Completion Date2029-07-31

Terms related to this study

Additional Relevant MeSH Terms

  • Sensorineural Hearing Loss
  • Cochlear Implantation
  • Perceptual Adaptation